251 millions
August 8th 2019
Patient Service suite
Patient Service suite
ResMed Services
Africa & Middle East
Asia Pacific
- Australia & New Zealand English
- India English
- Indonesia English
- Macau English
- Malaysia English
- Pakistan English
- Singapore English
- Hong Kong English
- Japan 日本語
- China 简体中文
- South Korea 한국어
- Taiwan 中國傳統的
- Thailand English
- Cambodia English
- Philippines English
- Vietnam English
- Myanmar English
- Laos English
- Brunei English
Country Selector
- Australia & New Zealand English
- India English
- Indonesia English
- Macau English
- Malaysia English
- Pakistan English
- Singapore English
- Hong Kong English
- Japan 日本語
- China 简体中文
- South Korea 한국어
- Taiwan 中國傳統的
- Thailand English
- Cambodia English
- Philippines English
- Vietnam English
- Myanmar English
- Laos English
- Brunei English
- Patient & Family
- Professionals
- Products
- Our company
- Our impact
Menu
Menu
Menu
Menu
Menu
-
- Online Sleep Assessment Start assessment
-
-
- Product support & documentation Read documentation
-
- Online Sleep Assessment Start assessment
-
-
- Product support & documentation Read documentation
> Professional > Treatment options for respiratory diseases > Home NIV in COPD > Clinical studies and solutions > 251 millions